Filing Flows

Filing Flows › Verrica Pharmaceuticals (VRCA) › How it makes money

How Verrica Pharmaceuticals (VRCA) makes money

Verrica Pharmaceuticals (VRCA) made $5.9M of revenue in the second quarter 2026 (Q2 2026), -54% from a year earlier.

Drawing the Sankey…

Verrica Pharmaceuticals: revenue by line, Q3 2025 to Q1 2026Verrica Pharmaceuticals: revenue by line, Q3 2025 to Q1 2026License and collabora…Product revenue, netLicense and collaboration revenue: $733K latestProduct revenue, net: $4.3M latest$4.3MQ3 2025Q4 2025Q1 2026
Product revenue, net went from 25% of revenue in Q3 2025 to 85% in Q1 2026, the largest shift in the mix.
Verrica Pharmaceuticals revenue by quarterVerrica Pharmaceuticals revenue by quarter$344KQ4 2024$3.4MQ1 2025$12.7MQ2 2025$14.3MQ3 2025$5.1MQ4 2025$5.0MQ1 2026$5.9MQ2 2026

Where each dollar of revenue goes

LineQ2 2026% of revenue
Revenue$5.9M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q2 2026$5.9M-54%
Q1 2026$5.0M+46%
Q4 2025$5.1M15×
Q3 2025$14.3M—
Q2 2025$12.7M+145%
Q1 2025$3.4M-10%
Q4 2024$344K-83%

From Verrica Pharmaceuticals' 10-Q filed Aug 6, 2026 (on EDGAR).

Questions

How does Verrica Pharmaceuticals make money?

Verrica Pharmaceuticals (VRCA) made $5.9M of revenue in the second quarter 2026 (Q2 2026), -54% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.